Navigation Links
Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease

Presentation of Final Phase I Monthly Implant and Phase IIa Daily Oral Results

LAUSANNE, Switzerland, June 11, 2007 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in oncology and serious medical conditions, presented final results of two Debio 9902 (formerly ZT-1) studies for the treatment of Alzheimer's disease (AD) at the Alzheimer's Association International Conference on the Prevention of Dementia, in Washington, DC:

- The phase I monthly sustained release implant study showed that Debio 9902 was well tolerated after repeated doses up to 15mg/per month and there were no safety concerns.

- The phase IIa once-daily oral study for a treatment period of 9 months showed that Debio 9902 was safe and effective in the treatment of moderate AD.

In a phase I study, healthy volunteers were administered once monthly subcutaneous injections of Debio 9902 SR implants up to 15mg. Sustained levels of Huperzine A (Hup A), the active metabolite of Debio 9902, were observed up to four weeks and Debio 9902 was well tolerated.

In a phase IIa study with the oral formulation of Debio 9902 in mild to moderate AD patients, improvements were observed on 3 efficacy scales, the assessment cognitive sub-scale (ADAS-cog), the Mini mental state examination (MMSE) and the Neuropsychiatric inventory questionnaire (NPI-Q). The study included a randomized part which lasted 3 months and which was followed by an additional 6 month open label part. The efficacy shown with the oral formulation, the good safety profile and the sustained release of Debio 9902 implants over one month have led to an ongoing phase II 'BRAINz' study in AD patients.

"The continuous release of Debio 9902 SR implants provides a new treatment alternative with the potential for better tolerance through a progressive, steady release of the active compound, therefore increasing p
'"/>




Page: 1 2 3

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Clinical Update Debio for Alzheimer Disease
(Date:5/24/2013)... , May 24, 2013 The ... for systemic delivery of therapeutic agents has been receiving ... drug delivery showing significant promise. The crucial formulation considerations ... delivery device play a major role in the efficiency ... in the development of new formulation techniques and devices ...
(Date:5/23/2013)... de mayo de 2013  Volcano Corporation (NASDAQ: ... fabricante de herramientas de precisión para terapia guiadas ... la enfermedad vascular periférica y coronaria, anunció hoy ... enosine V asodilator I ndependent ... sesión de ensayo clínico hot line late breaking ...
(Date:5/23/2013)... Nephros, Inc. (OTC Bulletin Board: ... develops and sells high performance liquid purification ultrafilters, announced ... addition, the concurrent temporary reduction in exercise price for ... 2013. Nephros estimates that it will receive ... A portion of the proceeds will be used for ...
Breaking Medicine Technology:Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... Calif., Sept. 27, 2011 The Wireless-Life Sciences Alliance ... 2011, where researchers from global institutions such as MIT, ... share the best new research and significant advances in ... government and industry. The conference is ...
... Sept. 27, 2011 In mid September, Harris Interactive ... for health care and which types of Medicare spending ... reduce the budget deficit.   Nearly four ... government should strengthen patients, access to home medical equipment ...
Cached Medicine Technology:Aging-in-Place Research Breakthroughs To Be Presented At Wireless Health 2011 Conference 2Aging-in-Place Research Breakthroughs To Be Presented At Wireless Health 2011 Conference 3Americans Favor Investment in Community and Home-Based Health Care, According to Harris Interactive Survey, September 2011 2Americans Favor Investment in Community and Home-Based Health Care, According to Harris Interactive Survey, September 2011 3
(Date:5/25/2013)... 2013 Radius Engineering International Inc., ... in the US and has been building concrete, ... 35 years. M.E. and President, Walton McCarthy, author ... Weapon Fundamentals and Shelter Engineering Standards, Sixth Edition, ... shelter engineering. McCarthy is considered the leading expert ...
(Date:5/25/2013)... 25, 2013 Providing patients with their best ... team of weight management professionals. But, aside from educating patients ... Diet Doc’s hCG diets also provide patients, who ... childhood like bullying, more control over their lives by achieving ... with the underlying factors of weight gain derived from earlier ...
(Date:5/25/2013)... May 25, 2013 On May 20, 2013 ... do not wish to discuss or plan for their eventual ... FuneralFinancials.com released a Must-Do List to help people ... Financials recommends, “Creating a personal fact sheet.” , While not ... financial information and personal data. It may include a ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 The ... ranging from irritable bowel syndrome (IBS) to bloating, ... among the most long-lasting, embarrassing, frustrating and difficult ... foods for digestive health have provided a ... are many factors contributing to digestive health issues, ...
(Date:5/25/2013)... York, NY (PRWEB) May 25, 2013 ... dedicated to brain cancer research and advocacy, comments on ... Extraterrestrial Physics, that shows incorporating cold atmospheric plasma into ... cells. , According to a Science Daily ... Extraterrestrial Physics (MPE), biologists and physicians demonstrated the “synergistic ...
Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2
... NEW YORK, July 13 Next week, the Center for ... in six states demonstrating that attacks, harassment, discriminatory legal restrictions and stigma ... reproductive rights. The report will be released at a briefing for ... July 22 , at 12:30 p.m. in room ...
... study by researchers from the Automotive Safety Program at Riley ... online July 13, 2009 in the journal Pediatrics ... needs are doing a good job with the selection of ... using it correctly. The study, one of the first ...
... ALISO VIEJO, Calif., July 13 Bausch & Lomb announced ... Administration (FDA) to market the Crystalens HD(TM) in quarter ... intraocular lens (IOL) was first approved by the FDA in November ... the celebration of the Crystalens HD first anniversary of ...
... , , CHICAGO, July 13 ... and fair 12-month budget that does not include deep cuts to ... to override Governor,s veto of (S.B. 1197) which included cutting human services programs ... the state have begun to lay off staff and close offices. , ...
... are not cognitively impaired, study finds , MONDAY, July 13 ... could cut their odds of Alzheimer,s and other cognitive decline ... as having one to two drinks a day, the study ... a nearly 40 percent drop in dementia risk, compared with ...
... , WASHINGTON, July 13 The American ... specialists, will honor six scientists who have made significant contributions to ... Ernest Beutler Lecture and Prize, will be presented at the 51st ... , , Past ASH president ...
Cached Medicine News:Health News: Making the difficult task of transporting a child with special needs safer 2Health News:Bausch & Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps 2Health News:Bausch & Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps 3Health News:Illinois Human Service Providers Announce Layoffs 2Health News:Illinois Human Service Providers Announce Layoffs 3Health News:Moderate Drinking Might Guard Against Alzheimer's 2Health News:Moderate Drinking Might Guard Against Alzheimer's 3Health News:Moderate Drinking Might Guard Against Alzheimer's 4Health News:Six Researchers to Receive Prestigious Awards from the American Society of Hematology 2Health News:Six Researchers to Receive Prestigious Awards from the American Society of Hematology 3
... is an easy-to-use, automated system that enables ... assays for managing hemostatic disordersincluding D-Dimer, Von ... offers reflex and rerun testing for greater ... by our high-quality service to help your ...
... Predictable Protection Made Easy. The new generation ... effectiveness and ease of use, providing you ... SVG stenting and angioplasty procedures., ,The FilterWire ... while requiring minimal changes to technique. ...
Representing the next step in the evolution of point-of-care testing, the i-STAT 1 Analyzer uses one platform to perform glucose strip testing along with all i-STAT test cartridges....
... 4194 Bipolar over-the-wire left-heart lead is for ... steroid-eluting lead has an angled shape and ... or a stylet delivery method, giving physicians ... position the lead in a variety of ...
Medicine Products: